Myalepta^®

(metreleptin powder for solution for injection)

RISK MINIMISATION

Imprint

Amryt Pharmaceuticals DAC

45 Mespil Road

Dublin 4

Ireland

Email: medinfo@amrytpharma.com

Free phone number: 00800 4447 4447

▼This medicine is subject to additional monitoring. This will allow quick identification of new safety information. Patients and Healthcare Professionals can help by reporting any side effects. Please see here for how to report any side effects.

Amryt Pharmaceuticals DAC, 45 Mespil Road, Dublin 4, Ireland. Medical Information details - email: medinfo@amrytpharma.com, phone: 00800 4447 4447

Code: C-MTA/UK/0045 Date of Preparation: February 2022

Terms of Use Imprint Privacy Policy Summary of Product Characteristics 3mg Summary of Product Characteristics 5.8mg Summary of Product Characteristics 11.3mg

© Amryt Pharma 2022.
Myalepta® is a registered trademark of the Amryt group. All rights reserved.

×

Video

Download Video

×

PACKAGE LEAFLETS

Package Leaflet 3mg Package Leaflet 5.8mg Package Leaflet 11.3mg